US2006116344A1PendingUtilityA1

Remedy and preventive for diseases caused by NF-kB

56
Assignee: ANGES MG INCPriority: May 12, 1995Filed: Jan 4, 2006Published: Jun 1, 2006
Est. expiryMay 12, 2015(expired)· nominal 20-yr term from priority
C12N 15/113C12N 2310/13C12N 2310/315A61K 48/005A61K 38/00A61P 9/10A61K 31/00A61P 35/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Administration of a decoy, i.e. a compound which specifically antagonizes the nucleic acid domain to which NF-κB is bound, is effective in the treatment and prevention of diseases caused by the transcriptional regulatory factor NF-κB, such as ischemic diseases, inflammatory diseases, autoimmune diseases, cancer metastasis and invasion, and cachexia.

Claims

exact text as granted — not AI-modified
1 . An NF-κB double-stranded decoy oligonucleotide, comprising a sense and an anti-sense strand, wherein the sequence comprises, in the 5′ to 3′ direction, SEQ ID NO: 1.  
     
     
         2 . An NF-κB double-stranded decoy oligonucleotide, comprising a sense and an anti-sense strand, wherein a strand consists of, in the 5′ to 3′ direction, SEQ ID NO: 1.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.